Table 1.
Patient demographic and disease characteristics
Patient’s Characteristics | OLN group | Control group | Chi-square test | |||
---|---|---|---|---|---|---|
% | N | % | N | P-value | ||
sex | male | 51.52 | 17 | 66.67 | 22 | 0.87 |
female | 48.48 | 16 | 33.33 | 11 | ||
Emetogenicity of chemotherapy drugs | H | 36.4 | 12 | 36.4 | 12 | 0.952 |
M | 30.3 | 10 | 27.2 | 9 | ||
H+M | 33.3 | 11 | 36.4 | 12 | ||
type of cancer | GIT | 6.1 | 2 | 6.1 | 2 | |
Genital | 15.2 | 5 | 6.1 | 2 | ||
ALL | 42.4 | 14 | 48.4 | 16 | ||
AML | 27.2 | 9 | 30.3 | 10 | ||
Multiple myeloma | 6.1 | 2 | 6.1 | 2 | ||
Sarchoma | 0 | 0 | 3 | 1 | ||
Respiratory | 3 | 1 | 0 | 0 |
H: Highly Emetogenic Chemotherapy, M: Moderately Emetogenic Chemotherapy, H+M: Highly +Moderately Emetogenic Chemotherapy, GIT: Gastric Intestinal Tract. ALL: Acute lymphocytic leukemia, AML: Acute myeloid Leukemia